Hyperemesis Gravidarum

Elevated Human Chorionic Gonadotropin (hCG) and Estrogen

• Rising hCG levels correlate with symptom onset and severity; hCG rapidly increases during the first trimester when HG symptoms are most severe
• hCG acts on trophoblastic tissue and may trigger chemoreceptor activation in the chemoreceptor trigger zone
• Estrogen levels rise exponentially during early pregnancy and have direct emetic effects via central nervous system receptors in the vomiting center and chemoreceptor trigger zone
• The temporal relationship between hCG/estrogen peaks and symptom onset/resolution supports this mechanism; women with molar pregnancies (markedly elevated hCG) have higher HG incidence
• These hormones sensitize the chemoreceptor trigger zone, lower the emetic threshold, and enhance gastric dysmotility

Gastric Dysmotility and Delayed Gastric Emptying

• Pregnancy hormones, particularly progesterone, decrease gastric muscle contractility and smooth muscle tone
• Decreased antral contractions and increased pyloric spasm reduce gastric emptying velocity (documented by gastric emptying studies in HG patients)
• Diminished antral-pyloric coordination creates a functional obstruction effect
• Combined with increased gastric sensitivity to cholecystokinin (CCK) and other peptide hormones, this creates a vicious cycle of retention, distension, and nausea
• This gastric dysfunction is physiologically necessary during pregnancy to increase nutrient absorption but becomes pathologic in HG

Immune Dysregulation and Inflammation

• Pregnancy represents an immunological paradox requiring tolerance of fetal alloantigens
• Elevated Th2 cytokines (IL-4, IL-10) and reduced Th1 responses characterize normal pregnancy immune adaptation
• In HG, exaggerated immune activation occurs with elevated TNF-α, IL-6, and other pro-inflammatory cytokines
• Possible mechanisms include molecular mimicry (fetal antigens cross-react with maternal antigens), aberrant maternal immune response to pregnancy antigens, or impaired regulatory T cell function
• Serum levels of inflammatory markers correlate with symptom severity, suggesting inflammation drives symptomatology
• This explains why immunosuppressive therapies show some efficacy in refractory cases

Helicobacter pylori Infection

• Some studies demonstrate higher H. pylori seropositivity in HG patients, though causality remains controversial
• If present, H. pylori infection triggers gastric inflammation and impaired gastric accommodation
• May predispose to or exacerbate gastric dysmotility in the setting of pregnancy-induced hormonal changes
• Not universally confirmed as a primary etiology but identified as a potential contributing factor in subsets of patients

Thyroid Dysfunction and hCG-Mediated TSH Suppression

• hCG shares structural homology with TSH and activates TSH receptors at high concentrations
• Marked hCG elevation (as in molar pregnancies or HG with high hCG levels) suppresses TSH and elevates free T4
• Thyroid hormone excess increases metabolic rate, gastric acid secretion, and GI motility dysregulation
• Some HG patients have documented transient thyroiditis or thyroid hormone elevation
• While thyroid dysfunction is not the primary cause, it may contribute to symptom severity in individual cases

Neurobiological Sensitization

• Repeated emetic episodes can trigger central sensitization in brainstem emetic centers
• Conditioned taste aversions and anticipatory nausea develop through learned associations
• Altered serotonin (5-HT3) and dopamine (D2) receptor signaling in the chemoreceptor trigger zone increases emetic sensitivity
• Dysfunction in the dorsal motor nucleus of the vagus and nucleus tractus solitarius impairs normal vomiting suppression mechanisms

Psychological Factors

• While HG is a physiologic condition, psychological stress, anxiety, and depression can amplify and perpetuate symptoms
• Negative emotions activate the chemoreceptor trigger zone and reduce vomiting threshold
• Conversely, the severe symptoms of HG generate secondary psychological morbidity
• This bidirectional relationship creates cycles of symptom amplification

Primary Risk Factors for Hyperemesis Gravidarum

• Young maternal age (<25 years): Younger women have higher incidence and severity; may reflect different immune maturation or hormonal sensitivity
• Multiple gestation (twins, triplets, etc.): Markedly elevated hCG levels from multiple trophoblastic tissues create higher hormone burden; approximately 3-fold increased risk compared to singleton pregnancies
• Molar pregnancy (hydatidiform mole): Extremely elevated hCG levels (often >100,000 mIU/mL vs. 50,000-100,000 in normal pregnancy at peak) produce severe HG in majority of cases; represents extreme end of hCG-symptom correlation spectrum
• Female fetal sex: Some studies document higher HG incidence with female fetuses, possibly related to different placental hormone production; however, data are inconsistent
• Nulliparity: First pregnancies have higher incidence, suggesting lack of prior tolerance development or immunologic priming
• Family history and genetic predisposition: Twin studies suggest 30-50% heritability; familial clustering occurs but specific genetic loci not definitively identified; may involve genetic variation in hormone receptors or inflammatory pathway genes

Contributing and Secondary Risk Factors

• Helicobacter pylori seropositivity: Presence of active or prior H. pylori infection increases risk in some populations, particularly in developing countries; eradication may improve symptoms in infected patients
• History of migraines or motion sickness: Suggests baseline increased susceptibility to nausea-emetic pathways; cross-talk between migraine and emetic centers in brainstem may predispose to HG
• Psychological factors: History of anxiety disorders, depression, or eating disorders; preexisting psychological distress amplifies HG severity (though HG itself is not psychogenic)
• Gastroesophageal reflux disease (GERD): Pre-pregnancy reflux symptoms increase risk; pregnancy progesterone further impairs lower esophageal sphincter (LES) tone
• Polycystic ovary syndrome (PCOS): Some association reported, possibly related to hormonal dysregulation or different placental development
• Hyperthyroidism or thyroid dysfunction: Pre-pregnancy thyroid disease increases risk; pregnancy-related thyroid changes may amplify HG risk

Conditions that Mimic or Complicate HG (Alternative Etiologies)

• Peptic ulcer disease or gastritis
• Hepatobiliary disease (cholecystitis, cholelithiasis, acute fatty liver)
• Appendicitis or other acute abdominal surgical pathology
• Eating disorders (requires careful assessment as patients may have pre-existing disorders)
• Central nervous system pathology (increased intracranial pressure, migraines)
• Uremia or diabetic ketoacidosis

Cardinal Symptoms

• Severe nausea: Unrelenting, often worse in morning but may persist throughout day; often described as constant and unbearable; triggers significant emotional distress
• Frequent vomiting: Multiple episodes daily (often >5-10 times daily in severe HG), which may be projectile in nature; can occur with minimal food intake
• Severe anorexia: Complete aversion to food, particularly protein-rich foods; weight loss results from reduced intake combined with vomiting losses
• Rapid weight loss: Typically ≥5% of pre-pregnancy body weight is diagnostic threshold; can progress to 10-15% in severe/untreated cases; loss occurs over 2-4 weeks initially

Associated Symptoms and Constitutional Features

• Dehydration symptoms: Thirst, decreased urination (oliguria), dry mucous membranes, orthostatic symptoms
• Electrolyte-related symptoms: Muscle weakness, cramping, palpitations (hypokalemia); confusion, lethargy (hyponatremia); constipation (hypercalcemia from dehydration hemoconcentration)
• Nutritional deficiency manifestations: Fatigue, weakness, cognitive impairment, mood changes (particularly with B-vitamin deficiency); glossitis or stomatitis (thiamine deficiency)
• Gastrointestinal disturbances: Abdominal pain or cramping (from gastric irritation and spasm), bloating, early satiety, constipation (from decreased intake and anticholinergic medication effects)
• Olfactory sensitivity: Heightened sense of smell (hyperolfaction) leading to food aversions; certain odors trigger nausea—this is a distinctive feature of pregnancy-related nausea

Physical Examination Findings

• Signs of dehydration: Decreased skin turgor, dry mucous membranes, tachycardia (resting HR often >90 bpm), orthostatic vital signs (orthostatic hypotension)
• Nutritional compromise: Weight loss documented on serial measurements, muscle wasting, decreased subcutaneous tissue, brittle hair or nails (with chronic deficiency)
• Abdominal examination: Typically benign; may have mild abdominal tenderness or distension; hyperactive or hypoactive bowel sounds depending on severity and medication use
• Neurological signs: May include peripheral neuropathy signs (diminished deep tendon reflexes, peripheral paresthesias) with thiamine deficiency; Wernicke's encephalopathy (ophthalmoplegic, ataxia, confusion) in severe untreated HG with thiamine depletion
• Vital sign abnormalities: Tachycardia (from dehydration and metabolic demands), potential tachypnea if metabolic acidosis present, fever absent (if present, suggests infection complicating HG)

Clinical Variants and Severity Spectrum

• Mild-moderate NVP: Nausea and occasional vomiting without significant weight loss or metabolic derangement; does not meet HG criteria but represents majority of pregnant women with nausea symptoms
• Severe HG with early-onset: Symptoms begin at 4-5 weeks and escalate rapidly; often most severe subtype
• Refractory HG: Persistent symptoms despite first and second-line antiemetic therapy; requires intensive management and hospitalization
• HG with psychiatric complications: Development of anticipatory anxiety, panic attacks, or depression secondary to severe symptoms
• HG with secondary gastric pathology: Prolonged vomiting leads to gastritis, esophagitis, or rarely Boerhaave syndrome (esophageal rupture)

Important Clinical Timeline

• Peak onset: Typically 8-12 weeks gestation (correlating with hCG peak)
• Peak symptom severity: Usually 11-13 weeks
• Resolution: Typically by 16-20 weeks in 80% of cases, though 10-20% have symptoms persisting into second or third trimester
• Rarely: Recurrence with multiple pregnancies or only in subsequent pregnancies

Clinical Diagnostic Approach

History and Diagnostic Criteria

• Onset timing: Nausea and vomiting beginning 4-8 weeks gestation (typically with positive pregnancy test or missed period); symptom severity rapidly escalates over first 2-3 weeks
• RCOG (Royal College of Obstetricians and Gynaecologists) diagnostic criteria:
• Persistent vomiting during pregnancy
• Associated with weight loss of ≥5% pre-pregnancy weight
• Ketonuria (indicating metabolic stress)
• Electrolyte abnormalities (hypokalemia, hyponatremia, hypochloremia)
• Severity assessment: Frequency of vomiting episodes (mild <3/day, moderate 3-5/day, severe >5/day); inability to maintain oral intake; impact on daily functioning
• Associated symptoms: Aversion to specific foods or odors; associated abdominal pain, heartburn, or constipation
• Exclusionary features suggesting alternative diagnosis: Blood in vomitus (esophageal pathology), abdominal pain out of proportion to findings, fever, diarrhea (infectious etiology)

Physical Examination Pearls

• Orthostatic vital signs: Blood pressure drop ≥20 mmHg systolic or ≥10 mmHg diastolic when changing from supine to standing; heart rate increase ≥20 bpm indicates significant dehydration
• Skin turgor assessment: Pinched skin on forearm should return to normal position within 2 seconds if hydration adequate; delayed return indicates dehydration
• Abdominal examination focusing on acute pathology: Rebound tenderness, guarding, or focal tenderness suggests surgical abdomen (appendicitis, cholecystitis) rather than simple HG; assess for hepatomegaly (liver disease), right upper quadrant tenderness (biliary disease)
• Neurological examination: Assess for nystagmus, ophthalmoplegia, or ataxia (signs of Wernicke's encephalopathy from thiamine depletion); deep tendon reflexes and distal sensation (peripheral neuropathy)

Laboratory and Diagnostic Testing

• Electrolyte panel (serum sodium, potassium, chloride, bicarbonate):
• Normal values in pregnancy: Physiologic hyponatremia occurs (128-132 mEq/L vs. 135-145 in non-pregnant); mild hypokalemia common
• HG pattern: Hypokalemia (K+ <3.0 mEq/L, often 2.0-2.5), hypochloremia (Cl- <95 mEq/L), often <90, hyponatremia exacerbated beyond physiologic level
• Acid-base status: Metabolic alkalosis common (from loss of gastric hydrochloric acid and hydrogen ions); pH >7.45 with elevated HCO3- >30 mEq/L typical
• Clinical significance: Severity of electrolyte abnormalities correlates with severity of HG and need for IV repletion; hypokalemia causes cardiac dysrhythmias and muscle weakness

• Complete metabolic panel including liver and renal function:
• Renal function: Elevated blood urea nitrogen (BUN) and creatinine indicate dehydration; BUN/Cr ratio typically >20 in prerenal azotemia from dehydration
• Liver function tests: Mild elevations of transaminases (ALT, AST) occur in 10-50% of HG (AST often >ALT); generally resolve with treatment; marked elevation (>500 IU/L) or hyperbilirubinemia suggests acute liver disease (acute fatty liver of pregnancy, HELLP)—more common in third trimester
• Albumin and total protein: May be low with prolonged malnutrition; indicates chronicity of illness

• Urinalysis with specific gravity and ketonuria:
• Specific gravity: Elevated >1.025 indicates dehydration (normal 1.005-1.020)
• Ketonuria: Presence of moderate to large ketonuria (≥2+ on dipstick) indicates ketosis from starvation; highly sensitive for HG severity
• Urine sodium and chloride: May be low, reflecting volume depletion
• Proteinuria: Small amounts may occur with dehydration; significant proteinuria (>1 g/24h) suggests preeclampsia (if in later pregnancy) or renal disease

• **Thyroid function tests

Immediate stabilisation (dehydration, ketosis, inability to tolerate oral intake)

• Isotonic crystalloid: normal saline or lactated Ringer's IV restores intravascular volume, corrects the hypochloremic metabolic alkalosis and prerenal azotemia, and reverses starvation ketosis.
• Thiamine before any dextrose: glucose loading accelerates thiamine consumption in transketolase-dependent pathways and can precipitate Wernicke encephalopathy. ACOG advises thiamine supplementation when vomiting has persisted beyond about three weeks or before dextrose-containing fluids.
• Potassium and magnesium repletion, guided by serial chemistries. Correct hyponatremia slowly to avoid osmotic demyelination.

First-line pharmacotherapy (ACOG Practice Bulletin 189, Nausea and Vomiting of Pregnancy)

• Vitamin B6 (pyridoxine), alone or combined with doxylamine: the only FDA-approved regimen for NVP; the antihistamine blocks H1 input to the vomiting center. Ginger and non-pharmacologic measures are reasonable adjuncts.
• Antihistamines/anticholinergics: dimenhydrinate, diphenhydramine, or scopolamine as add-on.

Escalation

• Dopamine D2 antagonists: promethazine or metoclopramide (also prokinetic, countering the delayed gastric emptying of pregnancy).
• 5-HT3 antagonists: ondansetron, highly effective but ACOG advises counselling about limited and conflicting data on orofacial clefts and cardiac septal defects with first-trimester exposure, and about QT prolongation.
• Corticosteroids: methylprednisolone reserved for refractory hospitalized cases; ACOG advises avoiding use before 10 weeks because of a possible cleft-lip signal.

Nutritional support ("definitive" management of refractory disease)

• Enteral tube feeding first, then parenteral nutrition only as a last resort because of catheter sepsis and thrombosis risk.

Avoid

• Dextrose before thiamine; rapid sodium correction; prolonged metoclopramide (tardive dyskinesia); IV push promethazine into a small vein (extravasation causes tissue necrosis/gangrene); and stacking QT-prolonging agents such as ondansetron with droperidol.

Maternal emergencies

• Wernicke encephalopathy (EMERGENCY): thiamine depletion from prolonged vomiting, often unmasked by dextrose infusion; confusion, ophthalmoplegia/nystagmus, ataxia. Can progress to irreversible Korsakoff amnesia or fetal loss. Treat with parenteral thiamine before glucose.
• Osmotic demyelination syndrome (EMERGENCY): iatrogenic, from correcting chronic hyponatremia too quickly; delayed quadriparesis, dysarthria, locked-in syndrome days after apparent improvement.
• Hypokalemia-related arrhythmia (EMERGENCY): loss of gastric H+ drives metabolic alkalosis with renal K+ wasting; U waves, QT prolongation, and torsades — a real hazard when ondansetron or droperidol is added.
• Boerhaave syndrome (EMERGENCY): full-thickness esophageal rupture from forceful emesis; severe chest pain, subcutaneous emphysema, Hamman crunch, pneumomediastinum on imaging.
• Mallory-Weiss tear: mucosal laceration at the gastroesophageal junction after retching; hematemesis following non-bloody vomiting.

Other maternal complications

• Prerenal acute kidney injury: volume depletion; BUN/creatinine ratio disproportionately elevated.
• Venous thromboembolism: dehydration superimposed on pregnancy hypercoagulability and immobility.
• Transient gestational thyrotoxicosis: hCG cross-stimulation of the TSH receptor; suppressed TSH with elevated free T4 but no goiter, orbitopathy, or thyroid antibodies — resolves without antithyroid drugs.
• Vitamin K and other micronutrient deficiency: prolonged poor intake; rarely maternal coagulopathy or fetal intracranial hemorrhage.
• Refeeding syndrome: insulin surge drives intracellular shift of phosphate, potassium, and magnesium after nutrition is restarted.
• Psychiatric morbidity: depression, anticipatory anxiety, and post-traumatic symptoms; also pregnancy termination requests in refractory disease.

Treatment-related

• Extrapyramidal reactions/tardive dyskinesia from metoclopramide or promethazine.
• Central line sepsis and thrombosis from parenteral nutrition.
• Hyperglycemia and possible first-trimester cleft risk with corticosteroids.

Fetal

• Fetal growth restriction, low birth weight, and preterm birth when weight loss is severe and sustained.

• The defining triad on a stem: intractable vomiting before 16 weeks + ≥5% loss of pre-pregnancy weight + dehydration with hypokalemic, hypochloremic metabolic alkalosis and ketonuria.
• Single best next step in a dehydrated, ketotic patient: IV isotonic fluid with thiamine given before any dextrose. Giving D5 first is the classic trap that precipitates Wernicke encephalopathy — remember the triad of confusion, ophthalmoplegia, and ataxia.
• First-line drug is not ondansetron. ACOG (Practice Bulletin 189) starts with pyridoxine (vitamin B6) ± doxylamine; ondansetron is escalation therapy, and stems reward you for choosing the B6/doxylamine combination.
• The association examiners love: extremely high hCG. Severe early hyperemesis with a uterus large for dates, no fetal heart tones, or theca lutein cysts should prompt pelvic ultrasound for hydatidiform mole; multiple gestation is the other high-hCG cause.
• Transient gestational thyrotoxicosis: suppressed TSH with high free T4 in a hyperemetic patient who has no goiter, no ophthalmopathy, and negative TSI/TRAb. Do not start methimazole or PTU — it resolves as hCG falls. Graves disease is the distractor.
• Electrolyte logic: vomiting loses HCl → metabolic alkalosis with paradoxical aciduria and renal potassium wasting. Correct hyponatremia slowly; rapid correction causes osmotic demyelination.
• Bloody emesis after repeated non-bloody vomiting = Mallory-Weiss tear; chest pain with subcutaneous emphysema and pneumomediastinum = Boerhaave syndrome, a surgical emergency.
• Nutrition escalation order: oral → enteral tube feeding → parenteral nutrition last, because TPN carries catheter sepsis and thrombosis risk in an already hypercoagulable patient.
• Distractor to avoid: hyperemesis is not psychogenic and is not managed with psychiatric admission alone, though secondary depression and anxiety are common and should be screened for.